AroCell AB (Sweden) Today
| AROC Stock | SEK 0.38 0.01 2.56% |
Performance0 of 100
| Odds Of DistressLess than 46
|
AroCell AB is selling for under 0.38 as of the 23rd of April 2024; that is -2.56 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.36. AroCell AB has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for AroCell AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
AroCell AB , a vitro diagnostics company, focuses on the monitoring of hematological malignancies, breast cancer, and other solid tumors. AroCell AB was founded in 2003 and is based in Uppsala, Sweden. AroCell AB is traded on Stockholm Stock Exchange in Sweden. The company has 230.36 M outstanding shares. More on AroCell AB
Moving together with AroCell Stock
| 0.82 | BEO-SDB | Beowulf Mining PLC | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AroCell Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AroCell AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AroCell AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Jan Stalemark |
| Business Concentration | Health Care, Life Sciences Tools & Services, Drug Manufacturers - Major, Healthcare (View all Sectors) |
AroCell AB (AROC) is traded on Stockholm Exchange in Sweden and employs 20 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 152.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AroCell AB's market, we take the total number of its shares issued and multiply it by AroCell AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AroCell AB operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 230.36 M outstanding shares.
AroCell AB has accumulated about 21.43 M in cash with (28.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check AroCell AB Probability Of Bankruptcy
Ownership AllocationAroCell AB retains a total of 230.36 Million outstanding shares. AroCell AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check AroCell Ownership Details
AroCell Stock Price Odds Analysis
Attributed to a normal probability distribution, the odds of AroCell AB jumping above the current price in 90 days from now is about 50.0%. The AroCell AB probability density function shows the probability of AroCell AB stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon AroCell AB has a beta of 0.2434. This suggests as returns on the market go up, AroCell AB average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding AroCell AB will be expected to be much smaller as well. Additionally, aroCell AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of AroCell AB to move above the current price in 90 days from now is about 50.0 (This AroCell AB probability density function shows the probability of AroCell Stock to fall within a particular range of prices over 90 days) .
AroCell AB Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. AroCell AB market risk premium is the additional return an investor will receive from holding AroCell AB long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AroCell AB. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although AroCell AB's alpha and beta are two of the key measurements used to evaluate AroCell AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.09 | |||
| Standard Deviation | 3.07 | |||
| Variance | 9.44 | |||
| Risk Adjusted Performance | 0.0024 |
AroCell Stock Against Markets
Picking the right benchmark for AroCell AB stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AroCell AB stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AroCell AB is critical whether you are bullish or bearish towards AroCell AB at a given time. Please also check how AroCell AB's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in AroCell AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Dashboard Now
Portfolio DashboardPortfolio dashboard that provides centralized access to all your investments |
| All Next | Launch Module |
AroCell AB Corporate Directors
AroCell AB corporate directors refer to members of an AroCell AB board of directors. The board of directors generally takes responsibility for the AroCell AB's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AroCell AB's board members must vote for the resolution. The AroCell AB board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Carl Blomqvist | Director | Profile | |
| Agneta Franksson | Director | Profile | |
| Christine Tadgell | Director | Profile | |
| Jan Mellberg | Director | Profile |
How to buy AroCell Stock?
Before investing in AroCell AB, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in AroCell AB. To buy AroCell AB stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of AroCell AB. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase AroCell AB stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located AroCell AB stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased AroCell AB stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as AroCell AB, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in AroCell AB?
The danger of trading AroCell AB is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AroCell AB is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AroCell AB. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AroCell AB is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AroCell AB. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for AroCell Stock analysis
When running AroCell AB's price analysis, check to measure AroCell AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AroCell AB is operating at the current time. Most of AroCell AB's value examination focuses on studying past and present price action to predict the probability of AroCell AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AroCell AB's price. Additionally, you may evaluate how the addition of AroCell AB to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| CEOs Directory Screen CEOs from public companies around the world |